"10.1371_journal.pone.0137210","plos one","2015-09-04T00:00:00Z","Yoko Tabe; Kensuke Kojima; Shinichi Yamamoto; Kazumasa Sekihara; Hiromichi Matsushita; Richard Eric Davis; Zhiqiang Wang; Wencai Ma; Jo Ishizawa; Saiko Kazuno; Michael Kauffman; Sharon Shacham; Tsutomu Fujimura; Takashi Ueno; Takashi Miida; Michael Andreeff","Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America; Department of Clinical Laboratory Medicine, Biomedical Research Center Graduate School of Medicine, Juntendo University, Tokyo, Japan; Leading Center for the Development and Research of Cancer Medicine, Biomedical Research Center Graduate School of Medicine, Juntendo University, Tokyo, Japan; Department of Laboratory Medicine, Tokai University of Medicine, Kanagawa, Japan; Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States of America; Laboratory of Proteomics and Biomolecular Science, Biomedical Research Center Graduate School of Medicine, Juntendo University, Tokyo, Japan; Karyopharm Therapeutics Inc., Natick, MA, United States of America","Conceived and designed the experiments: YT KK MA. Performed the experiments: YT KK SY KS ZW HM SK TF TU. Analyzed the data: YT KK JI RED MA WM. Contributed reagents/materials/analysis tools: MK SS. Wrote the paper: YT KK JI RED MA TM.","M. Andreeff received partial financial support for this study from Karyopharm Therapeutics Inc.(Newton, MA). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","09","Yoko Tabe","YT",16,TRUE,3,9,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
